Targeting the purinome
- PMID: 19727611
- DOI: 10.1007/978-1-60761-274-2_3
Targeting the purinome
Abstract
Purines are critical cofactors in the enzymatic reactions that create and maintain living organisms. In humans, there are approximately 3,266 proteins that utilize purine cofactors and these proteins constitute the so-called purinome. The human purinome encompasses a wide-ranging functional repertoire and many of these proteins are attractive drug targets. For example, it is estimated that 30% of modern drug discovery projects target protein kinases and that modulators of small G-proteins comprise more than 50% of currently marketed drugs. Given the importance of purine-binding proteins to drug discovery, the following review will discuss the forces that mediate protein:purine recognition, the factors that determine druggability of a protein target, and the process of structure-based drug design. A review of purine recognition in representatives of the various purine-binding protein families, as well as the challenges faced in targeting members of the purinome in drug discovery campaigns will also be given.
Similar articles
-
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.Chem Biol Drug Des. 2006 Jan;67(1):46-57. doi: 10.1111/j.1747-0285.2005.00316.x. Chem Biol Drug Des. 2006. PMID: 16492148
-
Importance of molecular computer modeling in anticancer drug development.J BUON. 2007 Sep;12 Suppl 1:S101-18. J BUON. 2007. PMID: 17935268 Review.
-
Form follows function: shape analysis of protein cavities for receptor-based drug design.Proteomics. 2009 Jan;9(2):451-9. doi: 10.1002/pmic.200800092. Proteomics. 2009. PMID: 19142949
-
Discovery of a new class of catalytic topoisomerase II inhibitors targeting the ATP-binding site by structure based design. Part I.Bioorg Med Chem Lett. 2009 Aug 1;19(15):4014-7. doi: 10.1016/j.bmcl.2009.06.034. Epub 2009 Jun 13. Bioorg Med Chem Lett. 2009. PMID: 19560355
-
The purinome, a complex mix of drug and toxicity targets.Curr Top Med Chem. 2006;6(11):1117-27. doi: 10.2174/156802606777812059. Curr Top Med Chem. 2006. PMID: 16842150 Review.
Cited by
-
In Search of a Role for Extracellular Purine Enzymes in Bone Function.Biomolecules. 2021 Apr 30;11(5):679. doi: 10.3390/biom11050679. Biomolecules. 2021. PMID: 33946568 Free PMC article. Review.
-
A naturally occurring, noncanonical GTP aptamer made of simple tandem repeats.RNA Biol. 2014;11(6):682-92. doi: 10.4161/rna.28798. Epub 2014 Apr 24. RNA Biol. 2014. PMID: 24824832 Free PMC article.
-
Crystal Structure-Guided Design of Bisubstrate Inhibitors and Photoluminescent Probes for Protein Kinases of the PIM Family.Molecules. 2021 Jul 19;26(14):4353. doi: 10.3390/molecules26144353. Molecules. 2021. PMID: 34299628 Free PMC article.
-
John Daly Lecture: Structure-guided Drug Design for Adenosine and P2Y Receptors.Comput Struct Biotechnol J. 2014 Oct 16;13:286-98. doi: 10.1016/j.csbj.2014.10.004. eCollection 2015. Comput Struct Biotechnol J. 2014. PMID: 25973142 Free PMC article. Review.
-
Therapeutic potential for P2Y2 receptor antagonism.Purinergic Signal. 2023 Jun;19(2):401-420. doi: 10.1007/s11302-022-09900-3. Epub 2022 Oct 11. Purinergic Signal. 2023. PMID: 36219327 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources